Response of the cyanobacterium Microcystis flos-aquae to levofloxacin

The effects of levofloxacin (LEV) on Microcystis flos-aquae and its mechanism were investigated by determining the responses of some parameters of M. flos-aquae to LEV stress, including growth inhibition ratio, chlorophyll a content, superoxide dismutase (SOD) and catalase (CAT) activities, malondialdehyde (MDA) content, F v/F 0 and F v/F m, etc. The results indicated that LEV at 0.001-0.1 μg L(-1) could stimulate the growth of M. flos-aquae and increase the chlorophyll a content but did not induce a significant increase in the activity of antioxidant enzymes (SOD and CAT) and the content of MDA. When the LEV concentration exceeds 10 μg L(-1), the growth of M. flos-aquae could be significantly inhibited (the highest inhibition ratio can be up to 88.38 % at 100 μg L(-1)) and chlorophyll a content, SOD and CAT activities, and MDA content also significantly decreased in a concentration-dependent manner, indicating that high concentrations of LEV caused a severe oxidative stress on algal cells, resulting in a large number of reactive oxygen species produced in algal cells and thereby inhibiting the growth of algae. At the same time, the F v/F m and F v/F 0 values of M. flos-aquae decreased significantly with both exposure time and increasing test concentration of LEV, showing that the process of photosynthesis was inhibited.

Effects of levofloxacin exposure on sequencing batch reactor (SBR) behavior and microbial community changes

The adaptation mechanisms of bacterial community for nitrogen removal performance exposed to fluctuated levels of levofloxacin (LVX) during wastewater treatment in SBRs were investigated. Although LVX is completely synthetic, the results of minimum inhibitory concentration (MIC, 32 mg-LVX/L) and minimum bactericidal concentration (MBC, 512 mg-LVX/L) of the sampled sludge showed that the LVX resistance/tolerance for bacterial growth has already existed in the actual wastewater treatment plants (WWTPs). The key bacteria, i.e. Nitrosomonas sp. (ammonia-oxidizing bacteria), Nitrospira sp. (nitrite-oxidizing bacteria) and Thauera sp. (the predominant denitrifiers), decreased with LVX exposure, and the recovery of biological process in the reactor was disturbed due to LVX exposure. However, after stopping exposure their population was quickly increased and thus the performance was recovered. The results of the non-metric multidimensional scaling and microbial community by sequencing showed the LVX concentration was a crucial factor to the change of bacterial communities and controlled the quantitative evolution of the communities in our systems. This effect was more pronounced as the LVX concentration was higher. The results suggested the removal of residual antibiotics to accomplish under no effect concentration before biological treatment is important to suppress emerging and increasing of the antibiotic resistant bacteria in WWTPs.

Levofloxacin and sulfamethoxazole induced alterations of biomolecules in Pseudokirchneriella subcapitata

Levofloxacin (LEV) and sulfamethoxazole (SMX) are two extensively used antibiotics. Most investigations have been concentrated on the toxic effects of antibiotics on algal species evaluated with traditional ecotoxicological endpoints; however, limited information is available on the alterations in biomolecules induced by antibiotics. Here we investigated alterations in the structure and function of biomolecules to a model species Pseudokirchneriella subcapitata following exposure of LEV and SMX by applying Fourier transform infrared spectroscopy (FTIR). The growth inhibition tests revealed that both LEV and SMX had negative effects on algal growth, while SMX was found to be more toxic to P. subcapitata than LEV. Based on the FTIR analysis, alterations in the structure, composition and function of lipids and proteins were observed on microalgal cells, which were correlated with the dosage of LEV and SMX. As a result of lipid peroxidation induced by LEV and SMX, an increase in the lipid/protein ratio and decrease in the ratios of CH₂/lipid, CH₃/lipid, carbonyl ester/lipid and olefinic = CH/lipid were observed in all treatment groups with respect to the reference control. Moreover, alterations in the composition and secondary structure of proteins were also observed in accompany with a decrease in the Amide I/Amide II ratio and an increase of the loose β-sheet structure protein. LEV caused an elevated level of lipid peroxidation, while SMX induced a more obvious protein aggregation. The findings from this study showed that FTIR could reveal the toxic mechanism of these two antibiotics to algae at the biochemical level by linking alterations in biomolecules to biochemical dynamics and function.

Oxidative transformation of levofloxacin by δ-MnO2: products, pathways and toxicity assessment

The characteristics of the oxidative transformation of the antibiotic levofloxacin (abbreviated as LEV) by manganese oxide were investigated. Up to 91% of LEV were removed with an equivalent of 200 units (abbreviated as equiv) of manganese oxide within a 35-day treatment period. A total of ten transformation products were identified, and five of them were newly reported. A tentative transformation pathway of LEV in the manganese oxide system involving oxidation and dealkylation was proposed. In addition, the variation in the genotoxicity and antibacterial activity along with the treatment by manganese oxide were traced using a SOS/umu assay and Escherichia coli growth inhibition assay, respectively. The results indicated that the genotoxicity significantly decreased in response to treatment with manganese oxide, while the antibacterial activity was not markedly affected until 160-equiv of δ-MnO2 were added. This study suggests that the oxidative degradation of LEV by manganese oxide can play an important role in the natural attenuation of LEV in sediment or soil matrices. The transformation reaction may be further optimized for removing quinolone antibiotics from wastewater or other environmental matrices to reduce the potential risk.

Bioassay- and QSAR-based screening of toxic transformation products and their formation under chlorination treatment on levofloxacin

Levofloxacin (LEV) is a broad-spectrum quinolone antibiotic and widely used for human and veterinary treatment. Overuse of LEV leads to its frequent occurrence in the water environment. In this study, the transformation characteristics of LEV in water during the simulated chlorination disinfection treatment were explored. Fifteen major transformation products (TPs) of LEV were identified, and their plausible formation pathways were proposed. The reaction pathways were strongly dependent on pH condition, and LEV removal was relevant to free available chlorine (FAC) dose. Antibacterial activity of chlorination system was dramatically declined when FAC was more than 3-equivalent (eq) due to the elimination of antibacterial related functional groups. Genotoxicity of chlorination system increased more than 3 times at 0.5-eq of FAC and then decreased with increasing FAC dose, which were in accordance with the relative concentration of toxic TPs estimated by QSAR model. These results implied that the combination of bioassay, QSAR computation and chemical analysis would be an efficient method to screen toxic TPs under chlorination treatment. It is anticipated that the results of this study can provide reference for optimizing operational parameters for water disinfection treatment, and for scientifically evaluating the potential risk of quinolone antibiotics.

Toxic effects of levofloxacin on rat annulus fibrosus cells: an in-vitro study

BACKGROUND

Fluoroquinolones are in wide clinical use as safe and effective antibiotics. Articular cartilage, tendons, and epiphyseal growth plates have been recognized as targets of fluoroquinolone-induced connective tissue toxicity. However, the effects of fluoroquinolones on annulus fibrosus (AF) cells are still unknown.

MATERIAL/METHODS

The main objective of this study was to investigate the effects of levofloxacin, a typical fluoroquinolone antibiotic drug, on rat AF cells in vitro. Rat annulus fibrosus (RAF) cells were treated with levofloxacin at different concentrations (0, 10, 20, 30, 40, 60, 80, and 90 μg/ml) and were assessed to determine the possible cytotoxic effects of levofloxacin. Inverted phase-contrast microscopy was used to accomplish the morphological observation of apoptosis of treated cells. Western blot and real-time quantitative RT-PCR (qPCR) was used to explore the expression of active caspase-3 and MMP-3. Flow cytometry was used to measure the apoptotic incidences.

RESULTS

Our study showed that levofloxacin, with concentrations at 30, 60, and 90 μg/ml, induced dose-dependent RAF cell apoptosis and higher expression of caspase-3 and MMP-3. More apoptotic cells were observed by inverted phase-contrast microscopy. Moreover, levofloxacin increased the activity of caspase-3, and it also reduced cell viability with different concentrations ranging from 10 to 80 μg/ml.

CONCLUSIONS

Our study results suggest that levofloxacin has cytotoxic effects on RAF cells, characterized by enhancing apoptosis and reducing cell viability, and indicate a potential toxic effect of fluoroquinolones on RAF cells.

Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model

Drug-induced liver injury induced by already approved substances is a major threat to human patients, potentially resulting in drug withdrawal and substantial loss of financial resources in the pharmaceutical industry. Trovafloxacin, a broad-spectrum fluoroquinolone, was found to have unexpected side effects of severe hepatotoxicity, which was not detected by preclinical testing. To address the limitations of current drug testing strategies mainly involving 2D cell cultures and animal testing, a three-dimensional microphysiological model of the human liver containing expandable human liver sinusoidal endothelial cells, monocyte-derived macrophages and differentiated HepaRG cells was utilized to investigate the toxicity of trovafloxacin and compared it to the structurally-related non-toxic drug levofloxacin. In the model, trovafloxacin elicited vascular and hepatocellular toxicity associated with pro-inflammatory cytokine release already at clinically relevant concentrations, whereas levofloxacin did not provoke tissue injury. Similar to in vivo, cytokine secretion was dependent on a multicellular immune response, highlighting the potential of the complex microphysiological liver model for reliably detecting drug-related cytotoxicity in preclinical testing. Moreover, hepatic glutathione depletion and mitochondrial ROS formation were elucidated as intrinsic toxicity mechanisms contributing to trovafloxacin toxicity.

Levofloxacin is phytotoxic and modifies the protein profile of lupin seedlings

The toxicity of levofloxacin to yellow lupin plants was evaluated in this study. Recommended indexes of plant (roots and shoots) growth were determined and new indexes were proposed which better characterise the phytotoxicity of levofloxacin. These were, in particular, the activity of antioxidative enzymes, the content of free radicals, as well as the root protein content and the root protein profile. The results showed that levofloxacin considerably affected EC₅₀, measured as the activity of catalase in roots, and leaves (1.05 and 0.069 mM, respectively). The activity of peroxidase in the roots and the dry weight of seedlings were the least sensitive parameters (EC₅₀ was 1.8 and 1.76 mM, respectively). Units of toxicity clearly showed that the activity of catalase is a better measure of toxicity for low concentrations of the drug, and it is a better index of plant physiological state than the morphological parameters of seedlings. Moreover, levofloxacin changed the location of free radicals and the protein profile in plants. The changes in location of reactive oxygen species in roots were an important symptom of the drug toxicity to lupin seedlings. Our results have shown that the toxicity of levofloxacin was manifested mainly by changes in the protein profile. The content of the glyceraldehyde-3-phosphate dehydrogenase, 14-3-3-like protein A, expansin-B3-like precursor, fructose-bisphosphate aldolase, lipoxygenase, nucleotide-binding subunit of vacuolar ATPase and pyruvate dehydrogenase were found to decrease. On the other hand, plant exposure to levofloxacin resulted in an increase in the content of enolase, protein LlR18A, class III chitinase, ascorbate peroxidase, aspartate aminotransferase, alcohol dehydrogenase 1, leghemoglobin reductase-like 17 and heat shock cognate protein 80-like.

Application of XCMS Online and toxicity bioassays to the study of transformation products of levofloxacin

We studied the nature and antimicrobial activity of ozonolysis transformation products (OTPs) of levofloxacin (LEV), a frequently detected fluoroquinolone antimicrobial in environmental waters. Two bioassays, the Kirby-Bauer test and the broth microdilution assay, were used to measure changes in the antimicrobial activity of solutions at low LEV to O3 molar ratios (2:1, 2:3 and 1:3) compared to solutions without added O3 (LEV:O3 1:0). The Kirby-Bauer test was not sensitive enough to detect significant differences in the growth inhibition zones in samples LEV:O3 2:1 and LEV:O3 1:0; however, the broth microdilution assay showed that bacterial growth inhibition was significantly lower (P<0.001) in the solutions exposed to O3. Loss of antimicrobial activity in LEV:O3 2:1 solutions of (48±16)% was in agreement with the concentration decrease of LEV of (36±3)% in those same samples. A method of identification of OTPs using XCMS Online was applied to LEV:O3 2:1 and 1:0 samples and indicated the presence of an OTP of LEV of formula C18H20O5N3F, which was identified as LEV-N-oxide. The molecular structure of this compound was partially confirmed by tandem mass spectrometry experiments. This study showed that even at sub-optimal ozone doses, OTPs of higher antimicrobial activity than LEV were not formed.

Prediction and mechanism of combined toxicity of surfactants and antibiotics in aquatic environment based on in silico method

The coexistence of surfactants and antibiotics in aquatic environments can potentially trigger combined toxic effects on aquatic organisms. Unfortunately, the effects of these joint toxins and the corresponding mechanism remain unclear. In this study, we performed individual and combined toxicity experiments involving surfactants and antibiotics. Six quantitative structure-activity relationship (QSAR) models and two traditional mixture models were developed. Moreover, the toxic mechanisms were explored with molecular dynamics (MD) simulations and density functional theory (DFT) calculations. The results shown that synergistic toxicity effects were observed in the binary mixture of levofloxacin (LEV) and octylphenol ethoxylate (Triton X-100). In addition, the best QSAR model (RF-PLS), which included four mixture descriptors (RDF155i#3, MATS3e#2, ETA_BetaP_ns#6, MLFER_E#6) exhibited excellent performance (R2 = 0.921, R2adj = 0.875, Q2LOO = 0.820, Q2ext = 0.889, and CCC = 0.954). Further analysis revealed that the electrostatic potential of different target chemicals and their binding ability with enzymes affected the activity of AChE of Daphnia magna, resulting in different toxicity. Specifically, in the AChE + Triton X-100 + LEV system, the second pollutant enhances the ability of the overall system to bind pollutants, which exhibit a synergistic effect during the binding process.